speb/financial-data huggingface dataset:
CLBT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 120805000.00
CLBT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 120805000.00
CLBT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 120805000.00
CLBT cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2188000.00
CLBT income_statement (annual, 2022-12-31) — Net Interest Income: 118871000.00
CLBT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -82146000.00
CLBT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 118871000.00
CLBT balance_sheet (annual, 2022-12-31) — Net PPE: 32912000.00
CLBT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -6897000.00
CLBT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 35782000.00
CLBT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 12511000.00
CLBT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 42173000.00
CLBT balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 42173000.00
CLBT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 12511000.00
CLBT income_statement (annual, 2022-12-31) — Normalized EBITDA: 129258000.00
CLBT income_statement (annual, 2022-12-31) — Normalized Income: 120154350.00
CLBT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 20577000.00
CLBT cash_flow (annual, 2022-12-31) — Operating Gains Losses: -36463000.00
CLBT income_statement (annual, 2022-12-31) — Operating Income: 1044000.00
CLBT income_statement (annual, 2022-12-31) — Operating Revenue: 270651000.00
CLBT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 193014155.00
CLBT balance_sheet (annual, 2022-12-31) — Other Current Assets: 8488000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 331000.00
CLBT income_statement (annual, 2022-12-31) — Other Gand A: 40854000.00
CLBT income_statement (annual, 2022-12-31) — Other Income Expense: 845000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 11254000.00
CLBT cash_flow (annual, 2022-12-31) — Other Non Cash Items: -81084000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1731000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 49110000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Payable: 2233000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Properties: 16199000.00
CLBT balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 95978000.00
CLBT income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 4694000.00
CLBT balance_sheet (annual, 2022-12-31) — Payables: 9698000.00
CLBT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 49437000.00
CLBT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 8597000.00
CLBT income_statement (annual, 2022-12-31) — Pretax Income: 120760000.00
CLBT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 13970000.00
CLBT balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLBT cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CLBT cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2188000.00
CLBT cash_flow (annual, 2022-12-31) — Purchase Of Investment: -165364000.00
CLBT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -6897000.00
CLBT balance_sheet (annual, 2022-12-31) — Raw Materials: 7451000.00
CLBT balance_sheet (annual, 2022-12-31) — Receivables: 78761000.00
CLBT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 50746000.00
CLBT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 9194000.00
CLBT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
CLBT income_statement (annual, 2022-12-31) — Research And Development: 80620000.00
CLBT balance_sheet (annual, 2022-12-31) — Retained Earnings: 199243000.00
CLBT cash_flow (annual, 2022-12-31) — Sale Of Investment: 83218000.00
CLBT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 97387000.00
CLBT income_statement (annual, 2022-12-31) — Selling General And Administration: 138241000.00
CLBT balance_sheet (annual, 2022-12-31) — Share Issued: 193055931.00
CLBT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 13708000.00
CLBT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 73865000.00
CLBT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 35782000.00
CLBT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 194350.00
CLBT income_statement (annual, 2022-12-31) — Tax Provision: -45000.00
CLBT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CLBT balance_sheet (annual, 2022-12-31) — Total Assets: 403293000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Capitalization: 73865000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Debt: 15356000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 73865000.00
CLBT income_statement (annual, 2022-12-31) — Total Expenses: 269607000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 329428000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 107362000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 121651000.00
CLBT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1044000.00
CLBT income_statement (annual, 2022-12-31) — Total Other Finance Cost: -116995000.00
CLBT balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2853000.00
CLBT income_statement (annual, 2022-12-31) — Total Unusual Items: 845000.00
CLBT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 845000.00
CLBT balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 41776.00
CLBT balance_sheet (annual, 2022-12-31) — Treasury Stock: 85000.00
CLBT balance_sheet (annual, 2022-12-31) — Working Capital: 88154000.00
CLBT income_statement (annual, 2023-12-31) — +Operating Expense: 238642000.00
CLBT income_statement (annual, 2023-12-31) — +Total Revenue: 325110000.00
CLBT balance_sheet (annual, 2023-12-31) — Accounts Payable: 8282000.00
CLBT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 77269000.00
CLBT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -33253000.00
CLBT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: -84896000.00
CLBT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -1583000.00
CLBT cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 3347000.00
CLBT cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 3347000.00
CLBT cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1106000.00
CLBT balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 28859000.00
CLBT income_statement (annual, 2023-12-31) — Basic Average Shares: 190154549.00
CLBT income_statement (annual, 2023-12-31) — Basic EPS: -0.43
CLBT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 87645000.00
CLBT cash_flow (annual, 2023-12-31) — Capital Expenditure: -7918000.00
CLBT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 14129000.00
CLBT balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
CLBT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 189517000.00
CLBT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 302923000.00
CLBT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
CLBT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 21765000.00
CLBT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -22540000.00
CLBT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 102058000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Account Payable: 3691000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Inventory: 243000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -1248000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -4075000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 46114000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Payable: 4425000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4425000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -9211000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Receivables: 2271000.00
CLBT cash_flow (annual, 2023-12-31) — Change In Working Capital: 38519000.00
CLBT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 2271000.00
CLBT cash_flow (annual, 2023-12-31) — Changes In Cash: 101283000.00
CLBT balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
CLBT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 34212000.00
CLBT income_statement (annual, 2023-12-31) — Cost Of Revenue: 53231000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 40272000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Assets: 422082000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4972000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4972000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 5550000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 196587000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 196587000.00
CLBT balance_sheet (annual, 2023-12-31) — Current Liabilities: 253824000.00
CLBT cash_flow (annual, 2023-12-31) — Deferred Income Tax: 5125000.00
CLBT cash_flow (annual, 2023-12-31) — Deferred Tax: 5125000.00
CLBT cash_flow (annual, 2023-12-31) — Depreciation: 6664000.00
CLBT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 10011000.00
CLBT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 10011000.00
CLBT balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 54117000.00
CLBT income_statement (annual, 2023-12-31) — Diluted Average Shares: 190154549.00
CLBT income_statement (annual, 2023-12-31) — Diluted EPS: -0.43
CLBT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -81100000.00
CLBT income_statement (annual, 2023-12-31) — EBIT: -75422000.00
CLBT income_statement (annual, 2023-12-31) — EBITDA: -65411000.00
CLBT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 589000.00
CLBT cash_flow (annual, 2023-12-31) — End Cash Position: 189517000.00
CLBT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 21765000.00
CLBT balance_sheet (annual, 2023-12-31) — Finished Goods: 2125000.00
CLBT cash_flow (annual, 2023-12-31) — Free Cash Flow: 94140000.00
CLBT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 34102000.00
CLBT cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CLBT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 206000.00
CLBT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1050000.00
CLBT income_statement (annual, 2023-12-31) — General And Administrative Expense: 43443000.00
CLBT balance_sheet (annual, 2023-12-31) — Goodwill: 26829000.00
CLBT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 37423000.00
CLBT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 78852000.00
CLBT balance_sheet (annual, 2023-12-31) — Gross PPE: 63409000.00
CLBT income_statement (annual, 2023-12-31) — Gross Profit: 271879000.00
CLBT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 10047000.00
CLBT balance_sheet (annual, 2023-12-31) — Income Tax Payable: 833000.00
CLBT income_statement (annual, 2023-12-31) — Interest Expense: 141000.00
CLBT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 141000.00
CLBT income_statement (annual, 2023-12-31) — Interest Income: 10575000.00
CLBT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 10575000.00
CLBT balance_sheet (annual, 2023-12-31) — Inventory: 9940000.00
CLBT balance_sheet (annual, 2023-12-31) — Invested Capital: 34212000.00
CLBT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -22540000.00
CLBT balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 28859000.00
CLBT balance_sheet (annual, 2023-12-31) — Investments And Advances: 28859000.00
CLBT balance_sheet (annual, 2023-12-31) — Leases: 7465000.00
CLBT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 9157000.00
CLBT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9157000.00
CLBT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 41102000.00
CLBT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CLBT income_statement (annual, 2023-12-31) — Net Income: -81100000.00
CLBT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -81100000.00
CLBT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -81100000.00
CLBT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -81100000.00
CLBT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -81100000.00
CLBT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -81100000.00
CLBT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -81100000.00
CLBT cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -2687000.00
CLBT income_statement (annual, 2023-12-31) — Net Interest Income: -109006000.00
CLBT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -14622000.00
CLBT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -109006000.00
CLBT balance_sheet (annual, 2023-12-31) — Net PPE: 30156000.00
CLBT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -5231000.00
CLBT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -3211000.00
CLBT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 7024000.00
CLBT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 47098000.00
CLBT balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 47098000.00
CLBT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 7024000.00
CLBT income_statement (annual, 2023-12-31) — Normalized EBITDA: -65617000.00
CLBT income_statement (annual, 2023-12-31) — Normalized Income: -81258620.00
CLBT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 102058000.00
CLBT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 34102000.00
CLBT income_statement (annual, 2023-12-31) — Operating Income: 33237000.00
CLBT income_statement (annual, 2023-12-31) — Operating Revenue: 325110000.00
CLBT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 203230928.00
CLBT balance_sheet (annual, 2023-12-31) — Other Current Assets: 16908000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1050000.00
CLBT income_statement (annual, 2023-12-31) — Other Gand A: 43443000.00
CLBT income_statement (annual, 2023-12-31) — Other Income Expense: 206000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 10594000.00
CLBT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 77509000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 7341000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 134477000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Payable: 2878000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Properties: 14842000.00
CLBT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 113406000.00
CLBT income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLBT balance_sheet (annual, 2023-12-31) — Payables: 11993000.00
CLBT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 52265000.00
CLBT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 9492000.00
CLBT income_statement (annual, 2023-12-31) — Pretax Income: -75563000.00
CLBT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 21765000.00
CLBT balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLBT cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CLBT cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -2687000.00
CLBT cash_flow (annual, 2023-12-31) — Purchase Of Investment: -144317000.00
CLBT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -5231000.00
CLBT balance_sheet (annual, 2023-12-31) — Raw Materials: 7815000.00
CLBT balance_sheet (annual, 2023-12-31) — Receivables: 77269000.00
CLBT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 53231000.00
CLBT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 10011000.00
CLBT income_statement (annual, 2023-12-31) — Research And Development: 84386000.00
CLBT balance_sheet (annual, 2023-12-31) — Retained Earnings: 118143000.00
CLBT cash_flow (annual, 2023-12-31) — Sale Of Investment: 129695000.00
CLBT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 110813000.00
CLBT income_statement (annual, 2023-12-31) — Selling General And Administration: 154256000.00
CLBT balance_sheet (annual, 2023-12-31) — Share Issued: 203272704.00
CLBT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 18998000.00
CLBT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 34212000.00
CLBT balance_sheet (annual, 2023-12-31) — Tangible Book Value: -3211000.00
CLBT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 47380.00
CLBT income_statement (annual, 2023-12-31) — Tax Provision: 5537000.00
CLBT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
CLBT balance_sheet (annual, 2023-12-31) — Total Assets: 532885000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Capitalization: 34212000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Debt: 14129000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 34212000.00
CLBT income_statement (annual, 2023-12-31) — Total Expenses: 291873000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 498673000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 110803000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 244849000.00
CLBT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 33237000.00
CLBT income_statement (annual, 2023-12-31) — Total Other Finance Cost: 119440000.00
CLBT balance_sheet (annual, 2023-12-31) — Total Tax Payable: 833000.00
CLBT income_statement (annual, 2023-12-31) — Total Unusual Items: 206000.00
CLBT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 206000.00
CLBT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 41776.00
CLBT balance_sheet (annual, 2023-12-31) — Treasury Stock: 85000.00
CLBT balance_sheet (annual, 2023-12-31) — Working Capital: 168258000.00
CLBT balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 0.00
CLBT cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 71271000.00
CLBT cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 1348000.00
CLBT cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -11000.00
CLBT cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 71271000.00
CLBT income_statement (annual, 2024-12-31) — +Operating Expense: 281704000.00
CLBT income_statement (annual, 2024-12-31) — +Total Revenue: 401203000.00
CLBT balance_sheet (annual, 2024-12-31) — Accounts Payable: 11077000.00
CLBT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 82358000.00
CLBT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -40036000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -40036000.00
CLBT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 498883000.00
CLBT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -594000.00
CLBT cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 3349000.00
CLBT cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 3349000.00
CLBT cash_flow (annual, 2024-12-31) — Amortization Of Securities: -2904000.00
CLBT balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 36601000.00
CLBT income_statement (annual, 2024-12-31) — Basic Average Shares: 209471827.00
CLBT income_statement (annual, 2024-12-31) — Basic EPS: -1.35
CLBT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 189517000.00
CLBT cash_flow (annual, 2024-12-31) — Capital Expenditure: -10609000.00
CLBT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 10969000.00
CLBT balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
CLBT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 191659000.00
CLBT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 447223000.00
CLBT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 20651000.00
CLBT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -149473000.00
CLBT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 132171000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Account Payable: 2755000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Inventory: 982000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 4994000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -3959000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 22317000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Payable: 20341000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 20341000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3201000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Receivables: -5829000.00
CLBT cash_flow (annual, 2024-12-31) — Change In Working Capital: 42047000.00
CLBT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -5829000.00
CLBT cash_flow (annual, 2024-12-31) — Changes In Cash: 3349000.00
CLBT balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
CLBT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 336020000.00
CLBT income_statement (annual, 2024-12-31) — Cost Of Revenue: 62593000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 56585000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 56585000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Assets: 567593000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 4125000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4125000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 5827000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 217636000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 217636000.00
CLBT balance_sheet (annual, 2024-12-31) — Current Liabilities: 295502000.00
CLBT cash_flow (annual, 2024-12-31) — Deferred Income Tax: -4015000.00
CLBT cash_flow (annual, 2024-12-31) — Deferred Tax: -4015000.00
CLBT cash_flow (annual, 2024-12-31) — Depreciation: 7258000.00
CLBT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 10607000.00
CLBT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 10607000.00
CLBT balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
CLBT balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
CLBT income_statement (annual, 2024-12-31) — Diluted Average Shares: 209471827.00
CLBT income_statement (annual, 2024-12-31) — Diluted EPS: -1.35
CLBT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -283007000.00
CLBT income_statement (annual, 2024-12-31) — EBIT: -275955000.00
CLBT income_statement (annual, 2024-12-31) — EBITDA: -265348000.00
CLBT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -1207000.00
CLBT cash_flow (annual, 2024-12-31) — End Cash Position: 191659000.00
CLBT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 20651000.00
CLBT balance_sheet (annual, 2024-12-31) — Finished Goods: 3005000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Finished Goods: 3005000.00
CLBT cash_flow (annual, 2024-12-31) — Free Cash Flow: 121562000.00
CLBT cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 110664000.00
CLBT cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
CLBT cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CLBT income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -1349000.00
CLBT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2086000.00
CLBT income_statement (annual, 2024-12-31) — General And Administrative Expense: 50900000.00
CLBT balance_sheet (annual, 2024-12-31) — Goodwill: 28714000.00
CLBT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 40020000.00
CLBT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 82952000.00
CLBT balance_sheet (annual, 2024-12-31) — Gross PPE: 67635000.00
CLBT income_statement (annual, 2024-12-31) — Gross Profit: 338610000.00
CLBT balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 553000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 553000.00
CLBT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 7706000.00
CLBT cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 3801000.00
CLBT balance_sheet (annual, 2024-12-31) — Income Tax Payable: 756000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 756000.00
CLBT income_statement (annual, 2024-12-31) — Interest Expense: 29000.00
CLBT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 29000.00
CLBT income_statement (annual, 2024-12-31) — Interest Income: 18229000.00
CLBT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 18229000.00
CLBT balance_sheet (annual, 2024-12-31) — Inventory: 8939000.00
CLBT balance_sheet (annual, 2024-12-31) — Invested Capital: 336020000.00
CLBT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -149473000.00
CLBT balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 36601000.00
CLBT balance_sheet (annual, 2024-12-31) — Investments And Advances: 36601000.00
CLBT balance_sheet (annual, 2024-12-31) — Leases: 8043000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Leases: 8043000.00
CLBT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 6844000.00
CLBT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 6844000.00
CLBT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 48403000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 48403000.00
CLBT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -2748000.00
CLBT cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CLBT income_statement (annual, 2024-12-31) — Net Income: -283007000.00
CLBT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -283007000.00
CLBT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -283007000.00
CLBT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -283007000.00
CLBT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -283007000.00
CLBT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -283007000.00
CLBT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -283007000.00
CLBT cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -2043000.00
CLBT income_statement (annual, 2024-12-31) — Net Interest Income: -331541000.00
CLBT cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -136116000.00
CLBT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -331541000.00
CLBT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -11000.00
CLBT cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
CLBT balance_sheet (annual, 2024-12-31) — Net PPE: 27599000.00
CLBT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -8566000.00
CLBT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 296000000.00
CLBT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 11072000.00
CLBT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 45247000.00
CLBT balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 45247000.00
CLBT balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 11072000.00
CLBT income_statement (annual, 2024-12-31) — Normalized EBITDA: -263999000.00
CLBT income_statement (annual, 2024-12-31) — Normalized Income: -281968270.00
CLBT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 132171000.00
CLBT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 110664000.00
CLBT cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
CLBT income_statement (annual, 2024-12-31) — Operating Income: 56906000.00
CLBT income_statement (annual, 2024-12-31) — Operating Revenue: 401203000.00
CLBT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 234524697.00
CLBT balance_sheet (annual, 2024-12-31) — Other Current Assets: 11799000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 2086000.00
CLBT income_statement (annual, 2024-12-31) — Other Gand A: 50900000.00
CLBT income_statement (annual, 2024-12-31) — Other Income Expense: -1349000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11306000.00
CLBT cash_flow (annual, 2024-12-31) — Other Non Cash Items: 228204000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 7682000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 6954000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Payable: 5323000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Properties: 11189000.00
CLBT balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 255564000.00
CLBT income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLBT balance_sheet (annual, 2024-12-31) — Payables: 17156000.00
CLBT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 73741000.00
CLBT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 10894000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 10894000.00
CLBT income_statement (annual, 2024-12-31) — Pretax Income: -275984000.00
CLBT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 20662000.00
CLBT balance_sheet (annual, 2024-12-31) — Properties: 0.00
CLBT balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CLBT cash_flow (annual, 2024-12-31) — Purchase Of Business: -2748000.00
CLBT cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CLBT cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -2043000.00
CLBT cash_flow (annual, 2024-12-31) — Purchase Of Investment: -334789000.00
CLBT cash_flow (annual, 2024-12-31) — Purchase Of PPE: -8566000.00
CLBT balance_sheet (annual, 2024-12-31) — Raw Materials: 5934000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Raw Materials: 5934000.00
CLBT balance_sheet (annual, 2024-12-31) — Receivables: 82358000.00
CLBT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 62593000.00
CLBT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10607000.00
CLBT income_statement (annual, 2024-12-31) — Research And Development: 98415000.00
CLBT balance_sheet (annual, 2024-12-31) — Retained Earnings: -164864000.00
CLBT cash_flow (annual, 2024-12-31) — Sale Of Investment: 198673000.00
CLBT income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 132389000.00
CLBT income_statement (annual, 2024-12-31) — Selling General And Administration: 183289000.00
CLBT balance_sheet (annual, 2024-12-31) — Share Issued: 234566473.00
CLBT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 30575000.00
CLBT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 336020000.00
CLBT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 296000000.00
CLBT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -310270.00
CLBT income_statement (annual, 2024-12-31) — Tax Provision: 7023000.00
CLBT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
CLBT balance_sheet (annual, 2024-12-31) — Total Assets: 690567000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Capitalization: 336020000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Debt: 10969000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 336020000.00
CLBT income_statement (annual, 2024-12-31) — Total Expenses: 344297000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 354547000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 122974000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 59045000.00
CLBT income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 56906000.00
CLBT income_statement (annual, 2024-12-31) — Total Other Finance Cost: 349741000.00
CLBT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 756000.00
CLBT balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 756000.00
CLBT income_statement (annual, 2024-12-31) — Total Unusual Items: -1349000.00
CLBT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1349000.00
CLBT balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 41776.00
CLBT balance_sheet (annual, 2024-12-31) — Treasury Stock: 85000.00
CLBT balance_sheet (annual, 2024-12-31) — Working Capital: 272091000.00
CLBT income_statement (quarterly, 2025-03-31) — +Operating Expense: 77791000.00
CLBT income_statement (quarterly, 2025-03-31) — +Total Revenue: 107549000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10214000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 81142000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 510153000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -661000.00
CLBT cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 926000.00
CLBT cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 926000.00
CLBT cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -523000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 100305000.00
CLBT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 237246654.00
CLBT income_statement (quarterly, 2025-03-31) — Basic EPS: 0.07
CLBT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 191659000.00
CLBT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2339000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 10603000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
CLBT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 90475000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 409486000.00
CLBT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3620000.00
CLBT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -126504000.00
CLBT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 20878000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1046000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Inventory: -10000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1941000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1567000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 992000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Payable: -13198000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -13198000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 5480000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1721000.00
CLBT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -4641000.00
CLBT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1721000.00
CLBT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -102006000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
CLBT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 363494000.00
CLBT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 17490000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Assets: 523482000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 4210000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4210000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 6260000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 219442000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 219442000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 287798000.00
CLBT cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -386000.00
CLBT cash_flow (quarterly, 2025-03-31) — Deferred Tax: -386000.00
CLBT cash_flow (quarterly, 2025-03-31) — Depreciation: 1705000.00
CLBT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2631000.00
CLBT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2631000.00
CLBT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 249302220.00
CLBT income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.07
CLBT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 17400000.00
CLBT income_statement (quarterly, 2025-03-31) — EBIT: 12268000.00
CLBT income_statement (quarterly, 2025-03-31) — EBITDA: 14899000.00
CLBT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 822000.00
CLBT cash_flow (quarterly, 2025-03-31) — End Cash Position: 90475000.00
CLBT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3620000.00
CLBT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 18539000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 890000.00
CLBT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 11746000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Goodwill: 28714000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 39636000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 81803000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 28027000.00
CLBT income_statement (quarterly, 2025-03-31) — Gross Profit: 90059000.00
CLBT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 806000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Inventory: 8969000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 363494000.00
CLBT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -126504000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 100305000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 100305000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 6393000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6393000.00
CLBT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CLBT income_statement (quarterly, 2025-03-31) — Net Income: 17400000.00
CLBT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 17400000.00
CLBT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 17400000.00
CLBT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 17400000.00
CLBT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 17400000.00
CLBT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 17400000.00
CLBT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 17400000.00
CLBT cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
CLBT income_statement (quarterly, 2025-03-31) — Net Interest Income: 7060000.00
CLBT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -124165000.00
CLBT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 7060000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Net PPE: 28027000.00
CLBT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2339000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 323858000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 11545000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 45641000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 45641000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 11545000.00
CLBT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 14899000.00
CLBT income_statement (quarterly, 2025-03-31) — Normalized Income: 17400000.00
CLBT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 20878000.00
CLBT income_statement (quarterly, 2025-03-31) — Operating Income: 12268000.00
CLBT income_statement (quarterly, 2025-03-31) — Operating Revenue: 107549000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 239470062.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 17625000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 890000.00
CLBT income_statement (quarterly, 2025-03-31) — Other Gand A: 11746000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 10922000.00
CLBT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -2380000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6897000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 6566000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Payable: 53932000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Properties: 28027000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 319011000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Payables: 64146000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 64146000.00
CLBT income_statement (quarterly, 2025-03-31) — Pretax Income: 19328000.00
CLBT cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 3620000.00
CLBT cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CLBT cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
CLBT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -213956000.00
CLBT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2339000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Receivables: 81142000.00
CLBT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 17490000.00
CLBT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2631000.00
CLBT income_statement (quarterly, 2025-03-31) — Research And Development: 27277000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -147464000.00
CLBT cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 89791000.00
CLBT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 38768000.00
CLBT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 50514000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Share Issued: 239511838.00
CLBT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 8777000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 363494000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 323858000.00
CLBT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLBT income_statement (quarterly, 2025-03-31) — Tax Provision: 1928000.00
CLBT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.10
CLBT balance_sheet (quarterly, 2025-03-31) — Total Assets: 709892000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 363494000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Total Debt: 10603000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 363494000.00
CLBT income_statement (quarterly, 2025-03-31) — Total Expenses: 95281000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 346398000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 186410000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 58600000.00
CLBT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 12268000.00
CLBT income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -7060000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 41776.00
CLBT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 85000.00
CLBT balance_sheet (quarterly, 2025-03-31) — Working Capital: 235684000.00
CLBT income_statement (quarterly, 2025-06-30) — +Operating Expense: 81182000.00
CLBT income_statement (quarterly, 2025-06-30) — +Total Revenue: 113276000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10587000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 93127000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 533847000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -574000.00
CLBT cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1661000.00
CLBT cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1661000.00
CLBT cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1202000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 85661000.00
CLBT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 240358573.00
CLBT income_statement (quarterly, 2025-06-30) — Basic EPS: 0.08
CLBT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 90475000.00
CLBT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3608000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 22331000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
CLBT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 179223000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 472184000.00
CLBT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 13826000.00
CLBT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 40577000.00
CLBT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 32583000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -166000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Inventory: -524000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1280000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -246000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 2310000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Payable: 17456000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 17456000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -2748000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -10931000.00
CLBT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 6597000.00
CLBT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -10931000.00
CLBT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 86986000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
CLBT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 408413000.00
CLBT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 17677000.00
CLBT balance_sheet (quarterly, 2025-06-30) — Current Assets: 606109000.00